Here it is copied and pasted:
Nine Lives
Speculation
Lots of questions as to what is happening here at CytoDyn. As the company doesn't speak, it gives rise to conjecture. So that is all we can do.
So there are some things that have been done to CytoDyn externally such as in the case of Amarex. There are also some things which have been done to CytoDyn internally, and although there wasn't significant impact financially, Cyrus' departure is an example of such an internal event which can speak to the direction the company is headed.
The majority of this post will deal with this prior external assault and the depths of their intentions and where they may be stemming from. I believe that Amarex/KK, was only a front man. They did not have anything against CytoDyn themselves, but they were likely handed incentives to do what they were instructed to do. Amarex/KK was not really the bad guy, but he agreed to do the dirty deed, however, he was put up to it. They knew that KK had the know how, and they provided the incentive.
What happened at CytoDyn was a result of it being in control of a block buster drug in the hands of a ultra-confident, know little, wild ass man, believing he was untouchable, that nothing could penetrate his defenses, even though, he didn't know the difference between his ass from his elbow. The powers that be, wanted the drug for themselves and so they decided that they needed to shut him down. They picked up on his flaws, as he advertised them to whoever cared to watch, where ever he was at, in any step he took. They knew precisely what his weak spot was and through their front man who was experienced and knew how to deceive, they played him by targeting his weak spot, over and over.
He executed their intentions precisely. It was planned perfectly; premeditated, well thought out destruction of the company via many means, some orchestrated by KK, some by his head, via slander, through false witness, by falsifying and corrupting the very documents which would have validated the drug. It was a very basic and dirty objective, but, an objective which would have worked wonderfully for them that is, had CytoDyn not had certain miracles take place which actually saved the company. Remember now the names of Sidley Austin and David Welch.
The head was very large and they laughed at the pint size CytoDyn. KK thought nothing of it either. He knew he and his team were capable to handle the work he needed to do. All involved, knew it was a fledgling company and they also knew that it was damn near bankrupt. They also knew its weakness which they targeted. They knew that the power of the drug resided in the validity of its data. They insured that by no means should the CRO permit CytoDyn access to the mal-formatted data. The plan they devised would modify and tweak the accepted protocol for the monitoring and recording of the clinical trial data and then also dis-allow the owner of that data, CytoDyn, the privilege of accessing that data, which, otherwise, would have provided CytoDyn the capacity to be a check reign on the CRO, checking up on their work, which CytoDyn was entitled to through the MSA, then, that plan would guarantee them that they could destroy CytoDyn completely, put it clean out of business, leaving it stranded in the street somewhere, left for dead, without any helping hand, forcing the patents on the drug to be sold for less than it was bought for, and so, via decision of the head, they proceeded exactly on that plan. They thought they had a sure win given the sheer paucity of CytoDyn, but, they failed to consider the power of miracles. They never counted on Sidley Austin attorneys entering the scene on behalf of CytoDyn.
Nobody really knows how or why Sidley Austin came to CytoDyn's rescue, but this grand law firm became involved when Amarex sued CytoDyn for the $13 MM or so which CytoDyn owed Amarex. Sidley Austin argued for CytoDyn's rights to the raw clinical trial data and access to that data was given provided that a bond of half the owed amount would be posted and just as fast as that was requested, no sooner was a bond posted for $6.5MM by a Mr. David Welch. This gave CytoDyn, via court injunction, the rights to garner the Raw Clinical Trial Data. After months of work with an "all hands on deck effort", employing many hired FDA type GCP Auditors, and expert counsel, a very careful analysis of that data was accomplished. A careful study of the data brought to light and uncovered exactly the type of games that were played upon CytoDyn and upon leronlimab. These discoveries were brought to the attention of Sidley Austin. As a result of these discoveries of utter breach of conduct, gross negligence and willful misconduct, in the nick of time, Sidley Austin was able to turn the case 180 degrees around and now CytoDyn has become the plaintiff and Amarex has become the defendant. Therefore, at this point, in arbitration, CytoDyn is the one doing the suing and Amarex is the one being sued. Resolution of this arbitration should be had by mid August 2024 and CytoDyn is seeking in excess of $100MM.
It was not Amarex who is surprised by the turn of events that Sidley Austin was able to achieve, but rather, the head which originally influenced Amarex to commit the deed in the first place. Yes, Amarex agreed to commit the deed, but they were not the one originally who was desiring that the deed be done. The question becomes then, who was the head behind this agenda? Who ever it is, plays a very dirty game, but, assuredly they know precisely how to use an old time tested agenda.
That agenda is dead set up to eliminate any and all competition. Serious competition. Competition such as leronlimab. Now, with over 1,500 patients to its credit, then, probably half that, BP knew full well then, the power that this molecule possessed and yet possesses. They very well knew of its affect on the HIV virus and its power to reduce viral load to zero and to maintain it down there, only in a matter of 1 or 2 injections, and all without causing a single adverse side effect. They very well knew, the consequences of its approval. The motivation to set up such an agenda is crystal clear to me. Because leronlimab posed the greatest threat at that time and still to this day in the HIV indication. Remember, at the time when this sabotage occurred, most of the clinical trials that had taken place, were in HIV and it was in the HIV-MDR indication in which this sabotage occurred.
Here there is more conjecture and speculation. So, I will ask many questions to see where that leads.
It is also possible that CytoDyn found itself targeted because of prior internal disputes between the CEO and the COB of the company, or other possible disputes between NP and other leaders such as Anthony Caracciolo COB. I think we know that AC brought Amarex to CytoDyn. Was there a reason why AC thought Amarex would be a good fit for CytoDyn? I was not around then so I can't really answer the question from a first or second hand perspective. At first glance, it is kind of interesting how both companies had a CEO of the same nationality. I also find it very interesting that AC had a C level leadership role at Gilead, and Gilead is the one BP that would be most threatened by a leronlimab approval. How do you destroy a potential enemy? By internally infiltrating it to destroy it from within; by becoming its parasite. How did AC acquire that C level role? The thinking of the head may have been to destroy CytoDyn/leronlimab from within, thereby allowing the head success in this destructive and collusive mission of wiping out CytoDyn and thereby allowing the head to carry out their overall grander mission of selling expensive bandaids, subsequently devoid of any significant competitor capable of wiping them out. What would it cost them? Only a few tens of millions of dollars paid over the years in Short Interest and they also would have to arrange for the quick and expedited purchase of their proxy, and maybe they paid a few hundred million there. Who knows, as long as CytoDyn was wiped out. Since the head was far stronger than the fledgling CytoDyn, they had zero concern of the company ever awakening from the dead, to rise up again in defense of itself. No, they thought it would die and fizzle out and never get up.
Never, in a million years did the instigating perpetrators of this crime ever expect that CytoDyn would live to see this day. Never would they believe that the FDA is damn near about to lift the hold on leronlimab. Never would they have thought that the BLA for HIV would again be submitted yet for a second time or that a CytoDyn CEO should be soon named or that a clinical combination trial in oncology is on the starting line slated for commencement. Surely, they never counted on the power of certain things which have happened to CytoDyn. Namely Sidley Austin and David Welch. Stated plainly, without David Welch, there would be no CytoDyn today. These two entities believe strongly in the asset leronlimab. David to the tune of 50MM shares. These are two very strong staunch believers. What happens to CytoDyn, happens to David Welch. In addition, neither the head nor KK never considered that Cyrus would come on board with a well conceived plan discussed within here which he executed upon and got us to where we stand today, with the submission in the FDA's hands right now and the clock ticking. There are also many others that are huge share holders who are also strong believers, just not quite as strong as Mr. Welch. It is mainly because of these two entities that CytoDyn remains up against the effort imposed upon CytoDyn to destroy it. All the staunch long shareholders surely have helped, but had it not been for these two, especially Mr. Welch, as well as the efforts of Cyrus Arman, I don't believe CytoDyn would be here today still fighting and now on the verge of winning.
The Day of Reckoning was the day the RTF was issued to CytoDyn when the BLA was not filed by the FDA. That was the day the instigating perpetrators got what they paid for ever since their proxy Amarex was hired by CytoDyn, brought in by AC. That was the day they knew they had won. They knew it was all down hill for CytoDyn from there even though Covid posed another CytoDyn opportunity which NP went after. The head wasn't worried about Covid, as a matter of fact, it was another day, in the Covid trial when 3 Adverse side effects were found in the Placebo Arm which forced CytoDyn to prove to the FDA that leronlimab was safe. But, because of what the CRO Amarex did, CytoDyn did not have the rights to its own clinical trial data on leronlimab, not even the raw data was accessible. CytoDyn therefore could not prove to the FDA, that leronlimab was safe, so the FDA had no choice but to impose the clinical hold upon leronlimab and lay it up now nearly 2 years in prison. That was the beginning of CytoDyn's huge decline thanks to the infiltrating power of the parasite Amarex.
Why wasn't CytoDyn allowed to have access to its own data? Why was CytoDyn put into this predicament? Was NP so gullible to believe everything KK told him? Were the perpetrators at all concerned that their overall plan would fail in any way? No, I don't think so. I think they knew all along that they had set it up in such a way, that it would take an absolute miracle for CytoDyn to right itself out of the shit show they put them in. The head knew they had them in quick sand and they were sinking fast.
But, CytoDyn did not squirm or struggle. CytoDyn stood still, became quiet, cool, calm collected and it started to rise up out of the sink hole. Through the help of both David Welch and Sidley Austin, they garnered the raw data and assembled it. Through the huge multi-month process of data analysis, they learned the depths of gross negligence and blatant misconduct which was in fact done to them. Cyrus was brought on to extricate CytoDyn from these deep, dark depths and he rose up to that challenge perfectly well. Cyrus spoke with confidence and he hired the required help in external audit committees. He sought and procured experts that would assist. He met in advisory meetings with the FDA. He cleaned up the company in the way which the FDA expected and he believed and understood the work he did would allow him to achieve his goals. All the while, Amarex was out of the picture. All the while Amarex was in arbitration with Sidley Austin. It was just Cyrus Arman and the FDA. Cyrus spoke their language.
Now, with Amarex in arbitration with SA, does anyone else yet carry out the dirty work which Amarex did? Not exactly, because CytoDyn is not running any trials currently. and Why would that even be necessary if leronlimab is still in prison? Because they know that they are dealing with leronlimab and even if it is in prison, there will be scientific articles and applications on the inhibition of the CCR5 receptor and the advantages of blocking CCR5. Regardless, lets try to answer the question with question. Who was behind Amarex? Who were the perpetrators that instigated? Through whom did Amarex originally come to CytoDyn? Does this company have any influence in the same HIV indication? Were there any meetings between Amarex and the head perpetrator prior to the original BLA submission? Prior to the RTF? Did Amarex/KK ever meet with the head perpetrator? If so, where? when? With who in particular? What was the purpose of the meeting? Did Amarex request advisement from the perpetrator, as to how to proceed with the BLA submission? Was their advice of good consequence or did it result in a poor outcome? Did it result in their overall achievement of their goals, though it cost Amarex their reputation? Were they successful in saving their HIV drug from the competition of leronlimab? Did they eradicate their HIV competition, but cost them their proxy?
Dirty deeds done dirt cheap. They don't play by the rules, but, in this world, only money talks. The Upmost concern here is that they must insure that the money keeps flowing. Can't stop that river from flowing. So anything goes. Do what ever is necessary to eradicate competition to protect the money supply. How? What is the incentive? Somehow, out of no where, Amarex gets purchased by NSF. That was something KK wanted from the get go. He wanted to be purchased for a big undisclosed sum. That surely happened. Why was NSF so interested in Amarex? Was NSF looking to get into the CRO business? or into the Pharmaceutical business? Was NSF actually aware of exactly what they were purchasing? Were they aware of the scheme? Was this just a ploy to disconnect Amarex from the head perpetrator? or is NSF and the head perpetrator yet still connected somehow?
NSF found out soon enough though, of who/what they actually purchased. They even agreed with CytoDyn's own Chris Recknor, that the data belonged to CytoDyn. They were baffled by the fact that Amarex held the data away from CytoDyn and told Chris Recknor, MD of CytoDyn that the data belonged to CytoDyn and was not theirs, not belonging to Amarex and not belonging to NSF. NSF found out that their purchase of Amarex plunged them headlong and headfirst into this collusion.
Conjecture: After their purchase of Amarex, at first, NSF had no idea that they were even involved in the brutal onslaught of CytoDyn and leronlimab. Later, they learned that it was their purchase of Amarex which actually helped the CRO to continue in their parasitic demolition of the company from the inside out. This purchase of Amarex actually has supported the original head perpetrator in their original quest to destroy CytoDyn and leronlimab. NSF actually helped the head perpetrator commit this deed and they had no idea. And they continue as NSF pay Amarex's attorneys in the arbitration. Was there any leader or relationship at NSF that may have been in cahoots with the head perpetrator? How did that deal of purchasing Amarex actually go down? Did NSF just have all that money to squander away on this CRO which never brought a drug to approval? Did NSF believe they may have had an opportunity to gain leronlimab through the purchase of Amarex? Could they have been deceived into making that purchase with promise of great treasures ahead? Deceived by who? By the perpetrator of course. Such power this perpetrator had, but just not strong enough to win in the end. They thought they had it covered from every angle. I guess they missed a few. CytoDyn still exists and is on the verge of being delivered as well.
So now CytoDyn might just have a new CEO that has a new CytoDyn to run. A man with a head on his shoulders. A man by the name of Salah, equipped with a moral compass, who is able to escalate this company along with this drug on the upward journey. Somehow, this drug has nine lives. He knows what is out there and what is pitted against this drug and with his experience, he knows how to protect it and how to keep it out of trouble and how to propagate it forward unto approval. And if not, then CytoDyn is to be bought out by a company with a CEO that knows how to do all of those same things. Our Prayers are being heard Longs!!
Nine Lives
Speculation
Lots of questions as to what is happening here at CytoDyn. As the company doesn't speak, it gives rise to conjecture. So that is all we can do.
So there are some things that have been done to CytoDyn externally such as in the case of Amarex. There are also some things which have been done to CytoDyn internally, and although there wasn't significant impact financially, Cyrus' departure is an example of such an internal event which can speak to the direction the company is headed.
The majority of this post will deal with this prior external assault and the depths of their intentions and where they may be stemming from. I believe that Amarex/KK, was only a front man. They did not have anything against CytoDyn themselves, but they were likely handed incentives to do what they were instructed to do. Amarex/KK was not really the bad guy, but he agreed to do the dirty deed, however, he was put up to it. They knew that KK had the know how, and they provided the incentive.
What happened at CytoDyn was a result of it being in control of a block buster drug in the hands of a ultra-confident, know little, wild ass man, believing he was untouchable, that nothing could penetrate his defenses, even though, he didn't know the difference between his ass from his elbow. The powers that be, wanted the drug for themselves and so they decided that they needed to shut him down. They picked up on his flaws, as he advertised them to whoever cared to watch, where ever he was at, in any step he took. They knew precisely what his weak spot was and through their front man who was experienced and knew how to deceive, they played him by targeting his weak spot, over and over.
He executed their intentions precisely. It was planned perfectly; premeditated, well thought out destruction of the company via many means, some orchestrated by KK, some by his head, via slander, through false witness, by falsifying and corrupting the very documents which would have validated the drug. It was a very basic and dirty objective, but, an objective which would have worked wonderfully for them that is, had CytoDyn not had certain miracles take place which actually saved the company. Remember now the names of Sidley Austin and David Welch.
The head was very large and they laughed at the pint size CytoDyn. KK thought nothing of it either. He knew he and his team were capable to handle the work he needed to do. All involved, knew it was a fledgling company and they also knew that it was damn near bankrupt. They also knew its weakness which they targeted. They knew that the power of the drug resided in the validity of its data. They insured that by no means should the CRO permit CytoDyn access to the mal-formatted data. The plan they devised would modify and tweak the accepted protocol for the monitoring and recording of the clinical trial data and then also dis-allow the owner of that data, CytoDyn, the privilege of accessing that data, which, otherwise, would have provided CytoDyn the capacity to be a check reign on the CRO, checking up on their work, which CytoDyn was entitled to through the MSA, then, that plan would guarantee them that they could destroy CytoDyn completely, put it clean out of business, leaving it stranded in the street somewhere, left for dead, without any helping hand, forcing the patents on the drug to be sold for less than it was bought for, and so, via decision of the head, they proceeded exactly on that plan. They thought they had a sure win given the sheer paucity of CytoDyn, but, they failed to consider the power of miracles. They never counted on Sidley Austin attorneys entering the scene on behalf of CytoDyn.
Nobody really knows how or why Sidley Austin came to CytoDyn's rescue, but this grand law firm became involved when Amarex sued CytoDyn for the $13 MM or so which CytoDyn owed Amarex. Sidley Austin argued for CytoDyn's rights to the raw clinical trial data and access to that data was given provided that a bond of half the owed amount would be posted and just as fast as that was requested, no sooner was a bond posted for $6.5MM by a Mr. David Welch. This gave CytoDyn, via court injunction, the rights to garner the Raw Clinical Trial Data. After months of work with an "all hands on deck effort", employing many hired FDA type GCP Auditors, and expert counsel, a very careful analysis of that data was accomplished. A careful study of the data brought to light and uncovered exactly the type of games that were played upon CytoDyn and upon leronlimab. These discoveries were brought to the attention of Sidley Austin. As a result of these discoveries of utter breach of conduct, gross negligence and willful misconduct, in the nick of time, Sidley Austin was able to turn the case 180 degrees around and now CytoDyn has become the plaintiff and Amarex has become the defendant. Therefore, at this point, in arbitration, CytoDyn is the one doing the suing and Amarex is the one being sued. Resolution of this arbitration should be had by mid August 2024 and CytoDyn is seeking in excess of $100MM.
It was not Amarex who is surprised by the turn of events that Sidley Austin was able to achieve, but rather, the head which originally influenced Amarex to commit the deed in the first place. Yes, Amarex agreed to commit the deed, but they were not the one originally who was desiring that the deed be done. The question becomes then, who was the head behind this agenda? Who ever it is, plays a very dirty game, but, assuredly they know precisely how to use an old time tested agenda.
That agenda is dead set up to eliminate any and all competition. Serious competition. Competition such as leronlimab. Now, with over 1,500 patients to its credit, then, probably half that, BP knew full well then, the power that this molecule possessed and yet possesses. They very well knew of its affect on the HIV virus and its power to reduce viral load to zero and to maintain it down there, only in a matter of 1 or 2 injections, and all without causing a single adverse side effect. They very well knew, the consequences of its approval. The motivation to set up such an agenda is crystal clear to me. Because leronlimab posed the greatest threat at that time and still to this day in the HIV indication. Remember, at the time when this sabotage occurred, most of the clinical trials that had taken place, were in HIV and it was in the HIV-MDR indication in which this sabotage occurred.
Here there is more conjecture and speculation. So, I will ask many questions to see where that leads.
It is also possible that CytoDyn found itself targeted because of prior internal disputes between the CEO and the COB of the company, or other possible disputes between NP and other leaders such as Anthony Caracciolo COB. I think we know that AC brought Amarex to CytoDyn. Was there a reason why AC thought Amarex would be a good fit for CytoDyn? I was not around then so I can't really answer the question from a first or second hand perspective. At first glance, it is kind of interesting how both companies had a CEO of the same nationality. I also find it very interesting that AC had a C level leadership role at Gilead, and Gilead is the one BP that would be most threatened by a leronlimab approval. How do you destroy a potential enemy? By internally infiltrating it to destroy it from within; by becoming its parasite. How did AC acquire that C level role? The thinking of the head may have been to destroy CytoDyn/leronlimab from within, thereby allowing the head success in this destructive and collusive mission of wiping out CytoDyn and thereby allowing the head to carry out their overall grander mission of selling expensive bandaids, subsequently devoid of any significant competitor capable of wiping them out. What would it cost them? Only a few tens of millions of dollars paid over the years in Short Interest and they also would have to arrange for the quick and expedited purchase of their proxy, and maybe they paid a few hundred million there. Who knows, as long as CytoDyn was wiped out. Since the head was far stronger than the fledgling CytoDyn, they had zero concern of the company ever awakening from the dead, to rise up again in defense of itself. No, they thought it would die and fizzle out and never get up.
Never, in a million years did the instigating perpetrators of this crime ever expect that CytoDyn would live to see this day. Never would they believe that the FDA is damn near about to lift the hold on leronlimab. Never would they have thought that the BLA for HIV would again be submitted yet for a second time or that a CytoDyn CEO should be soon named or that a clinical combination trial in oncology is on the starting line slated for commencement. Surely, they never counted on the power of certain things which have happened to CytoDyn. Namely Sidley Austin and David Welch. Stated plainly, without David Welch, there would be no CytoDyn today. These two entities believe strongly in the asset leronlimab. David to the tune of 50MM shares. These are two very strong staunch believers. What happens to CytoDyn, happens to David Welch. In addition, neither the head nor KK never considered that Cyrus would come on board with a well conceived plan discussed within here which he executed upon and got us to where we stand today, with the submission in the FDA's hands right now and the clock ticking. There are also many others that are huge share holders who are also strong believers, just not quite as strong as Mr. Welch. It is mainly because of these two entities that CytoDyn remains up against the effort imposed upon CytoDyn to destroy it. All the staunch long shareholders surely have helped, but had it not been for these two, especially Mr. Welch, as well as the efforts of Cyrus Arman, I don't believe CytoDyn would be here today still fighting and now on the verge of winning.
The Day of Reckoning was the day the RTF was issued to CytoDyn when the BLA was not filed by the FDA. That was the day the instigating perpetrators got what they paid for ever since their proxy Amarex was hired by CytoDyn, brought in by AC. That was the day they knew they had won. They knew it was all down hill for CytoDyn from there even though Covid posed another CytoDyn opportunity which NP went after. The head wasn't worried about Covid, as a matter of fact, it was another day, in the Covid trial when 3 Adverse side effects were found in the Placebo Arm which forced CytoDyn to prove to the FDA that leronlimab was safe. But, because of what the CRO Amarex did, CytoDyn did not have the rights to its own clinical trial data on leronlimab, not even the raw data was accessible. CytoDyn therefore could not prove to the FDA, that leronlimab was safe, so the FDA had no choice but to impose the clinical hold upon leronlimab and lay it up now nearly 2 years in prison. That was the beginning of CytoDyn's huge decline thanks to the infiltrating power of the parasite Amarex.
Why wasn't CytoDyn allowed to have access to its own data? Why was CytoDyn put into this predicament? Was NP so gullible to believe everything KK told him? Were the perpetrators at all concerned that their overall plan would fail in any way? No, I don't think so. I think they knew all along that they had set it up in such a way, that it would take an absolute miracle for CytoDyn to right itself out of the shit show they put them in. The head knew they had them in quick sand and they were sinking fast.
But, CytoDyn did not squirm or struggle. CytoDyn stood still, became quiet, cool, calm collected and it started to rise up out of the sink hole. Through the help of both David Welch and Sidley Austin, they garnered the raw data and assembled it. Through the huge multi-month process of data analysis, they learned the depths of gross negligence and blatant misconduct which was in fact done to them. Cyrus was brought on to extricate CytoDyn from these deep, dark depths and he rose up to that challenge perfectly well. Cyrus spoke with confidence and he hired the required help in external audit committees. He sought and procured experts that would assist. He met in advisory meetings with the FDA. He cleaned up the company in the way which the FDA expected and he believed and understood the work he did would allow him to achieve his goals. All the while, Amarex was out of the picture. All the while Amarex was in arbitration with Sidley Austin. It was just Cyrus Arman and the FDA. Cyrus spoke their language.
Now, with Amarex in arbitration with SA, does anyone else yet carry out the dirty work which Amarex did? Not exactly, because CytoDyn is not running any trials currently. and Why would that even be necessary if leronlimab is still in prison? Because they know that they are dealing with leronlimab and even if it is in prison, there will be scientific articles and applications on the inhibition of the CCR5 receptor and the advantages of blocking CCR5. Regardless, lets try to answer the question with question. Who was behind Amarex? Who were the perpetrators that instigated? Through whom did Amarex originally come to CytoDyn? Does this company have any influence in the same HIV indication? Were there any meetings between Amarex and the head perpetrator prior to the original BLA submission? Prior to the RTF? Did Amarex/KK ever meet with the head perpetrator? If so, where? when? With who in particular? What was the purpose of the meeting? Did Amarex request advisement from the perpetrator, as to how to proceed with the BLA submission? Was their advice of good consequence or did it result in a poor outcome? Did it result in their overall achievement of their goals, though it cost Amarex their reputation? Were they successful in saving their HIV drug from the competition of leronlimab? Did they eradicate their HIV competition, but cost them their proxy?
Dirty deeds done dirt cheap. They don't play by the rules, but, in this world, only money talks. The Upmost concern here is that they must insure that the money keeps flowing. Can't stop that river from flowing. So anything goes. Do what ever is necessary to eradicate competition to protect the money supply. How? What is the incentive? Somehow, out of no where, Amarex gets purchased by NSF. That was something KK wanted from the get go. He wanted to be purchased for a big undisclosed sum. That surely happened. Why was NSF so interested in Amarex? Was NSF looking to get into the CRO business? or into the Pharmaceutical business? Was NSF actually aware of exactly what they were purchasing? Were they aware of the scheme? Was this just a ploy to disconnect Amarex from the head perpetrator? or is NSF and the head perpetrator yet still connected somehow?
NSF found out soon enough though, of who/what they actually purchased. They even agreed with CytoDyn's own Chris Recknor, that the data belonged to CytoDyn. They were baffled by the fact that Amarex held the data away from CytoDyn and told Chris Recknor, MD of CytoDyn that the data belonged to CytoDyn and was not theirs, not belonging to Amarex and not belonging to NSF. NSF found out that their purchase of Amarex plunged them headlong and headfirst into this collusion.
Conjecture: After their purchase of Amarex, at first, NSF had no idea that they were even involved in the brutal onslaught of CytoDyn and leronlimab. Later, they learned that it was their purchase of Amarex which actually helped the CRO to continue in their parasitic demolition of the company from the inside out. This purchase of Amarex actually has supported the original head perpetrator in their original quest to destroy CytoDyn and leronlimab. NSF actually helped the head perpetrator commit this deed and they had no idea. And they continue as NSF pay Amarex's attorneys in the arbitration. Was there any leader or relationship at NSF that may have been in cahoots with the head perpetrator? How did that deal of purchasing Amarex actually go down? Did NSF just have all that money to squander away on this CRO which never brought a drug to approval? Did NSF believe they may have had an opportunity to gain leronlimab through the purchase of Amarex? Could they have been deceived into making that purchase with promise of great treasures ahead? Deceived by who? By the perpetrator of course. Such power this perpetrator had, but just not strong enough to win in the end. They thought they had it covered from every angle. I guess they missed a few. CytoDyn still exists and is on the verge of being delivered as well.
So now CytoDyn might just have a new CEO that has a new CytoDyn to run. A man with a head on his shoulders. A man by the name of Salah, equipped with a moral compass, who is able to escalate this company along with this drug on the upward journey. Somehow, this drug has nine lives. He knows what is out there and what is pitted against this drug and with his experience, he knows how to protect it and how to keep it out of trouble and how to propagate it forward unto approval. And if not, then CytoDyn is to be bought out by a company with a CEO that knows how to do all of those same things. Our Prayers are being heard Longs!!
